Atlas Trials

Emalex Biosciences Inc.

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Emalex Biosciences Inc.

RecordFirmDate
Food-effect Study of Ecopipam Pharmacokinetics (NCT06669091)Emalex Biosciences Inc.2024-11-05
Drug Interaction Study (NCT06194864)Emalex Biosciences Inc.2024-01-18
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder (NCT06021522)Emalex Biosciences Inc.2023-08-16
Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization (NCT05841160)Emalex Biosciences Inc.2023-03-15
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults (NCT05615220)Emalex Biosciences Inc.2023-01-31
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport (NCT05334108)Emalex Biosciences Inc.2022-04-26
Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite (NCT04902105)Emalex Biosciences Inc.2021-05-13
Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects (NCT04881955)Emalex Biosciences Inc.2021-05-12
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates (NCT04764851)Emalex Biosciences Inc.2021-02-18
Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely) (NCT04492956)Emalex Biosciences Inc.2020-10-02
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension (NCT04114539)Emalex Biosciences Inc.2019-10-04
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents (NCT04007991)Emalex Biosciences Inc.2019-06-28

Track Emalex Biosciences Inc. automatically

Every clearance here is in the API, with alerts when new ones post.